One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

Similar documents
Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Clinical Guidelines Update (aka Know Your NAATs)

Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet. Jordan, Stephen J. MD, PhD; Geisler, William M.

Extragenital Gonorrhea and Chlamydia among MSM

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think?

Answers to those burning questions -

LYMPHOGRANULOMA VENEREUM PRESENTING AS PERIANAL ULCERATION: AN EMERGING CLINICAL PRESENTATION?

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

Services for GLBTQ Youth

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE

Extra-Genital Infections: Seek and Ye Shall Find

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

STIs: Practical Aspects of Management

Professor Jonathan Ross. Dr Melinda Tenant-Flowers. University Hospitals Birmingham NHS Trust. King s College Hospital NHS Foundation Trust, London

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

STI Indicators by STI

UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland

STIs- REVISION. Prof A A Hoosen

Lymphogranuloma Venereum (LGV) Surveillance Project

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Extragenital Chlamydia and Gonorrhea. Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016

CLINICAL MANAGEMENT OF STDS

Management of NGU (Non-gonococcal urethritis)

Recent HIV infections- GMHS 2012

WHAT DO U KNOW ABOUT STIS?

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016

STDs and Hepatitis C

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Clinical Cases from the STD Clinical Consultation Network

Testing, Treating and Managing STIs Dr Jean Irvine

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs

Disclosure Information Julie Stoltey, MD MPH

Professor Jonathan Ross

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS

Learning Objectives. STI Update. Case 1 6/1/2016

Departments of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

Extra-genital STIs: An update. Luis F. Barroso, M.D. Associate Professor Wake Forest Baptist Health

What's the problem? - click where appropriate.

3/28/2016. Why you should care? Dana W. Dunne, MD, FACP Associate Professor of Medicine Yale University School of Medicine New Haven, Connecticut

Chapter 11. Sexually Transmitted Diseases

5/1/2017. Sexually Transmitted Diseases Burning Questions

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Chlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University

Update on Sexually Transmitted Infections among Persons Living with HIV

STI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council

STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention

The cost-effectiveness of screening men who have sex with men for rectal chlamydial and

Sexually Transmitted Infection Treatment and HIV Prevention

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011

S403- Update on STIs for the Generalists

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Sexually Transmitted Diseases

Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011

Dr Claudia Estcourt. Barts and the London School of Medicine and Dentistry THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Treatment Trends for South African MSM. Kevin Rebe

DETECTION OF NEISSERIA GONORRHOEAE USING MOLECULAR METHODS

Incidence des IST chez les PrEPeurs

Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

Sexually Transmitted Diseases

Overview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017

Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE

The Impact of HIV Risk Reduction Behaviours on Sexually Transmissible Infections in HIV Negative Homosexual Men

Trends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems

Dual Therapy: Symptoms and Screening:

Epidemiology of ano-rectal STIs in Asia. Montreux, 2008

Chlamydia trachomatis and Neisseria gonorrhoeae are the

GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS

TRICHOMONAS VAGINALIS

Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis Genc M, Mardh P A

Say Ahhh!, STDs in Maine. Emer Smith, Maine CDC,

The Synergy between HIV and other STIs

World Journal of Colorectal Surgery

Professor Adrian Mindel

Family Planning Title X Chlamydia Screening Quality Improvement Project

National STD Conference

4. Chlamydia. Treatment: Treating infected patients prevents further transmission to sex partners. In addition, treatment of chlamydia in pregnant

Chlamydia Curriculum. Chlamydia. Chlamydia trachomatis

Nothing to disclose.

Chlamydia trachomatis

Original Study. Culture of Non-Genital Sites Increases the Detection of Gonorrhea in Women

Clinical Practice Objectives

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers

STDs among Men who Have Sex with Men (MSM), San Francisco

Challenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A

STD Prevention Among Youth

STIs in the Indian Country

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

Reviewing Sexual Health and HIV NM2715

STI Diagnostics Redesign. HVS and Chlamydia Resource Pack

2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE

Clinical Education Initiative ADOLESCENTS AND STDS: CASE STUDIES. Tara Babu, MD

Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual men

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None

Transcription:

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV Background Rectal CT infection is the most prevalent bacterial STI in MSM (4-11%). It is usually asymptomatic Rectal LGV is seen commonly in London MSM but almost all is symptomatic infection [1]. STIs increase risk for HIV acquisition and transmission. Re-infection with rectal CT or GC is associated with increased risk of HIV seroconversion [2]. 1.Ward et al, STI 2009 Jun 2.Bernstein et al, JAIDS 2009 Nov

Background The BASHH guidelines recommend doxycycline 100 mg bid for 7 days or azithromycin 1g stat for the treatment of uncomplicated CT infections, including rectal. Evidence is robust for genital infections but scant for rectal CT. Steedman et al [1] reported that 87% (59/68) of asymptomatic rectal CT was cleared with single-dose azithromycin 1g po. 1.Steedman et al, Int J STD AIDS 2009 Jan Objective To determine the efficacy of a 7-day doxycycline regimen for treatment of asymptomatic rectal CT infection.

Methods Routine screening for rectal CT since 2005 using NAAT. BD ProbeTec SDA 2005-2008 GenProbe Aptima Combo2 2008-2010 All MSM with asymptomatic rectal CT offered doxycycline 100mg bid for 7 days and invited for a TOC 4 weeks after the completion of treatment. Case note review of asymptomatic rectal CT cases between Sep 06-Sep 09. Results 766 cases of rectal CT were diagnosed in study period. 487 (64%) were asymptomatic infections. 293 TOC were performed 41 of which were excluded due to missing data or development of anorectal symptoms after testing. 252 TOC in 241 MSM were analysed.

Patient characteristics n=252 Characteristic N (%) Median age, years (IQR) 31 (26-38) Ethnicity n=241 White 165 (68%) Black 18 (8%) Other 30 (12%) Unknown 30 (12%) Known HIV positive 49 (19%) Past history of STI 158 (63%) Receptive anal intercourse 211 (83%) Reason for attendance (%) n=252 29% 8% 7% 56% Asymptomatic screening Genital symptoms General symptoms Contact of CT

Concurrent STI diagnoses (%) n=252 20 16 % 15 12 10 5 6 2 5 3 0 Urethral GC Throat GC Rectal GC Urethral CT New Syphilis New HIV Treatment details n=252 7-day doxycycline regimen 100mg twice daily 191 (76%) Doxycycline for 14 days 35 (14%) Azithromycin 1 g 26 (10%)

TOC results Median time post-treatment for TOC was 45 days (IQR 34-88). 70 (28%) negative tests were performed 4 weeks after treatment. Out of 252 TOC, 11 were positive (4%). TOC results Of the 11 positive TOC: 4/11 had been treated with azithromycin 1g. 6/11 had taken doxycycline for one week. One patient was treated with 3 weeks of doxycycline: He re-attended 57 days post-treatment as a contact of CT (TOC positive). He was retreated with doxycycline for 1 week (TOC was negative).

Characteristics of MSM with treatment failure Characteristic Azithromycin Doxycycline treatment failure N=4 Treatment failure N=6 Past history of STIs 1 1 Known HIV positive 1 1 New HIV infection 0 3 New bacterial STI at time of TOC 0 4 LGV typing for positive samples 0 3 (all LGV-negative) at TOC TOC median time, days (range) 36 (23-328) 257 (34-438) Re-treatment with 7-day 2 5 doxycycline regimen Negative subsequent TOC 2/2 3/3 Summary Most (64%, 487/766) of MSM with rectal CT infection had no anorectal symptoms. The majority (84%, 212/252) of asymptomatic rectal CT infections occurred without concurrent genital CT.

Summary After exclusion of likely re-infection and noncompliant cases, a 7-day doxycycline course achieved clearance of CT in 99.5% (185/186). Azithromycin 1g cleared 85% (22/26) of rectal CT infection. Summary Routine TOC following compliance with a 7-day course of doxycycline is not necessary in the absence of anorectal symptoms. We advocate doxycycline as first line therapy for rectal CT and advise TOC if azithromycin is used. A randomised trial of anti-chlamydial treatment for rectal infection is warranted.

Acknowledgement Clinical and laboratory staff at GSTT Laboratory staff at STBRL in Colindale Co-authors